Quince Therapeutics, Inc. (QNCX) — Analyst estimates
Consensus analyst estimates for Quince Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.25 | 2 |
| 2027 | 17.05M | -1.25 | 1 |
| 2028 | 292.37M | -0.56 | 2 |
| 2029 | 486.33M | -1.12 | 1 |
| 2030 | 705.84M | -1.02 | 1 |
Consensus analyst estimates by fiscal year.